AMANDA FUTRELL: Open Payments
NPI 1568857621 · SCOTLAND NECK, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 46 payments from 16 companies in 2025. Trend: 2023 $835 · 2024 $848 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $126 |
| Lilly USA, LLC | 18 | $123 |
| Novo Nordisk Inc | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Amgen Inc. | 3 | $50 |
| Corcept Therapeutics | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, OTEZLA, Rybelsus, Korlym, FARXIGA, Wegovy.
Industry payments across NC — which companies pay providers there.
